Noriyuki Masuda

Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer

Riichiroh Maruyama, Yutaka Nishiwaki, Tomohide Tamura et al. · Journal of Clinical Oncology · 2008 · 364 citations · Full text

Phase II Trial of Amrubicin for Treatment of Refractory or Relapsed Small-Cell Lung Cancer: Thoracic Oncology Research Group Study 0301

Sayaka Onoda, Noriyuki Masuda, Takashi Seto et al. · Journal of Clinical Oncology · 2006 · 226 citations

Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors

Taroh Satoh, Isamu Okamoto, Masaki Miyazaki et al. · Clinical Cancer Research · 2009 · 175 citations

Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer

Terufumi Kato, Noriyuki Masuda, Yoichi Nakanishi et al. · Lung Cancer · 2016 · 104 citations · Full text

Deconjugation of Bile Salts by <i>Bacteroides</i> and <i>Clostridium</i>

Noriyuki Masuda · Microbiology and Immunology · 1981 · 93 citations · Full text

Biochemistry, Resting Cells, Bacteriology +6